• Home
  • Company
    • Management
    • Board of Directors
    • Advisory Board
  • Technology
    • Publications
  • Partnering
    • Product Pipeline
  • News
    • IN THE PRESS: Cloud Pharmaceuticals CSO Shahar Keinan in "The Scientist"
    • Cloud Pharmaceuticals to Present AI-Based Drug Design at Conferences in May
    • Cloud Pharmaceuticals Wins U.S.-China Health Summit
    • Cloud Pharmaceuticals Selected Finalist in U.S.-China Health Summit
    • Cloud Pharmaceuticals forms Drug Design Collaboration with GSK
    • Cloud Pharmaceuticals CEO to Speak at Artificial Intelligence in Drug Development Congress 27-28 September 2017, London, UK
    • Cloud Pharmaceuticals CEO and CSO to Speak at AI Pharma Innovation
    • Cloud Pharmaceuticals CEO to Speak at the AI in Pharma Summit October17, 2017 in Boston.
    • Cloud Pharmaceuticals CEO and CSO to Speak at AI Pharma Innovation
    • Undruggable? Not to Cloud Pharmaceuticals
    • Cloud Pharmaceuticals Announces Design of Active Pro-Drug for Treatment of Crohn's Disease and Ulcerative Colitis
    • Cloud Pharmaceuticals COO to Discuss Digital Tools for Drug Discovery and Development at the 2016 BIO International Convention
    • Cloud Pharmaceuticals Appoints Neurological Disorder Expert Jeff Vaught to Its Advisory Board
    • Cloud Pharmaceuticals Strengthens Management Team with Appointment of Two C-Level Executives
  • Events
  • Contact
Cloud Pharmaceuticals
Connect with us:

Board of Directors

Ed Addison
Chairman and CEO of Cloud Pharmaceuticals

Mr. Addison is CEO of Cloud Pharmaceuticals. With a background in biomedical engineering and business, Addison is an established serial entrepreneur in both information technology and the life sciences. He is also a director for Quantum Cures Foundation. Addison's recent career focus has been on life sciences ventures that have a significant IT underpinning. Prior to Cloud Pharmaceuticals, he was CTO at Inclinix in Wilmington, NC, advisor to BioFortis and BioSequent, and CEO of several IT ventures.



Rob Armstrong, PhD
Former VP Discovery Chemistry and Research Technologies for Lilly

Rob Armstrong is the Chief Executive Officer, board member, and co-founder of Boston Pharmaceuticals. With over twenty years of experience working in research and development in the biopharmaceutical industry, Dr. Armstrong has been involved in the discovery and clinical development of programs across multiple disease areas. Dr. Armstrong created and led the small molecule R&D organization at Amgen in Thousand Oaks, CA. He subsequently co-led research at Lilly as Vice President of Global Medicinal Chemistry, was head of the translational medicine group Chorus, and was Vice President of Global External R&D. He served on the finance and scientific advisory boards of Lilly BioVentures. Prior to working in industry, Dr. Armstrong was a tenured Professor of Chemistry and Biochemistry at the University of California at Los Angeles. He received his BS in chemistry at UCSD, his Ph.D. in chemistry at CSU, and was an NIH postdoctoral fellow at Harvard. He is an advisor to Gelesis and serves on the board of directors of early stage biotechnology companies Curza Therapeutics, Cloud Pharmaceuticals, Entrega Bio, and Artax Biopharma.



Michael Brennan, MD-PhD
Founder and Former CEO of Gene Logic

Dr. Brennan is the founder, president, and former CEO of Gene Logic (NASDAQ: GLGC). His experience as successful entrepreneur for a biotech company that uses information as a key part of its business model translates especially well to Cloud Pharmaceuticals. During Dr. Brennan’s time at Gene Logic, he built the company from a start-up to a public company that achieved a market capitalization of over $5 billion. Dr. Brennan was previously a general partner at Oxford Bioscience Partners. He also served as vice president, business development for Boehringer Mannheim Therapeutics.



Lawrence Husick
CIO of Cloud Pharmaceuticals

Mr. Husick has twenty-seven years of experience as a chemist, technology consultant, computer system designer, software author, and company founder, as well as twenty-four years of experience as an intellectual property lawyer.  This diverse background gives him a unique perspective on the issues of management and innovation. 


​
Michael Sikora
COO of Holland and Knight, LLP

Mr. Sikora is a CPA and business executive. He is currently the COO for the law firm Finnegan, Henderson, Farrabow, Garett & Dunner. He offers Cloud Pharmaceuticals strategic and tactical advice on a broad range of issues including merger/acquisition evaluation, due diligence and integration, and operational and financial matters.


HOME | COMPANY | TECHNOLOGY | PARTNERING | NEWS | EVENTS | CONTACT

CONTACT US:

Cloud Pharmaceuticals, Inc.

Office: 800 Park Offices Dr., RTP, NC 27709
Mail: PO Box 110081, RTP, NC 27709
Phone: 1.910.398.1200
e-mail: info@cloudpharmaceuticals.com
CONNECT WITH US:


SUBSCRIBE:

Join our contact list to receive news and announcements in your inbox:

Join Now
© 2014 - 2019 Cloud Pharmaceuticals, Inc. | Terms and Conditions of access to www.cloudpharmaceuticals.com